The ADREU social science team are focused on gaining a better understanding of the impacts of novel technologies on the patient experience. We utilise social science methods alongside our patient and public involvement (PPI) programme to describe potential positive and/or negative potential impacts of disruptive technologies. Working closely with industry allows our programme of work to directly influence the design choices technology experts make, and provides the opportunity for our partners to produce high impact technology with greater potential for adoption.
Our social science studies are informed by our close collaborations with clinicians, patients and the public. If you are a healthcare professional or member of the public interested in participating in our Community Advisory Group, or if you are a diagnostic technology expert and want to know more about how to utilise our expertise, please contact us.
Our work includes:
The Precise study social science programme runs alongside programmes of work to develop and evaluate new diagnostic tests for Chlamydia, Gonorrhoea, and Mycoplasma genitalium as well as antibiotic resistance marker identification for Gonorrhoea and Mycoplasma. We have interviewed patients in three clinics around England (London, Devon, and Yorkshire) to better understand patient priorities for their visit to sexual health services, and their opinions and expectations for rapid diagnostics in these settings. Please visit the Precise study website for more information.
In this study we tested methods to study the impact the diagnosis of Non-Specific Non-Gonococcal Urethritis (NSNGU) on male heterosexual patients. We asked men who are attending a sexual health clinic in London to complete two questionnaires, one before seeing the doctor (in the waiting room) and one after laboratory test results for Chlamydia and Gonorrhoea are returned to them. Some were also invited to a one-on-one interview to explore their responses to the questionnaires. Please contact us to learn more about this study.